astrazeneca death in service trustee limited Company Information
Company Number
04145522
Next Accounts
Sep 2025
Industry
Non-trading company
Shareholders
astrazeneca uk ltd
Group Structure
View All
Contact
Registered Address
1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA
Website
www.astrazeneca.co.ukastrazeneca death in service trustee limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED at £0 based on a Turnover of £0 and 0.52x industry multiple (adjusted for size and gross margin).
astrazeneca death in service trustee limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED at £0 based on an EBITDA of £0 and a 9.89x industry multiple (adjusted for size and gross margin).
astrazeneca death in service trustee limited Estimated Valuation
Pomanda estimates the enterprise value of ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED at £1 based on Net Assets of £1 and 1.2x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Astrazeneca Death In Service Trustee Limited Overview
Astrazeneca Death In Service Trustee Limited is a live company located in cambridge, CB2 0AA with a Companies House number of 04145522. It operates in the non-trading company sector, SIC Code 74990. Founded in January 2001, it's largest shareholder is astrazeneca uk ltd with a 100% stake. Astrazeneca Death In Service Trustee Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Astrazeneca Death In Service Trustee Limited Health Check
There is insufficient data available to calculate a health check for Astrazeneca Death In Service Trustee Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Death In Service Trustee Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Astrazeneca Death In Service Trustee Limited
- - Industry AVG
ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED financials
Astrazeneca Death In Service Trustee Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Astrazeneca Death In Service Trustee Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | 0 | 0 | 0 | 0 | |||||||||||
Number Of Employees | |||||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
net assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total shareholders funds | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | ||||||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | ||||||||||
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
astrazeneca death in service trustee limited Credit Report and Business Information
Astrazeneca Death In Service Trustee Limited Competitor Analysis
Perform a competitor analysis for astrazeneca death in service trustee limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in CB2 area or any other competitors across 12 key performance metrics.
astrazeneca death in service trustee limited Ownership
ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED group structure
Astrazeneca Death In Service Trustee Limited has no subsidiary companies.
Ultimate parent company
2 parents
ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED
04145522
astrazeneca death in service trustee limited directors
Astrazeneca Death In Service Trustee Limited currently has 4 directors. The longest serving directors include Mr Adrian Kemp (Sep 2010) and Mr Timothy Cordier (Aug 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Adrian Kemp | United Kingdom | 58 years | Sep 2010 | - | Director |
Mr Timothy Cordier | United Kingdom | 51 years | Aug 2020 | - | Director |
Mr Matthew Bowden | United Kingdom | 47 years | Jan 2021 | - | Director |
Ms Rachel Redman | United Kingdom | 33 years | Aug 2024 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
astrazeneca death in service trustee limited company details
company number
04145522
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
January 2001
age
23
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
ayzee 7 limited (December 2010)
accountant
-
auditor
-
address
1 francis crick avenue, cambridge biomedical campus, cambridge, CB2 0AA
Bank
-
Legal Advisor
-
astrazeneca death in service trustee limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to astrazeneca death in service trustee limited.
astrazeneca death in service trustee limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ASTRAZENECA DEATH IN SERVICE TRUSTEE LIMITED. This can take several minutes, an email will notify you when this has completed.
astrazeneca death in service trustee limited Companies House Filings - See Documents
date | description | view/download |
---|